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Adeno-Associated Virus Rep Represses the Human Integration Site
Promoter by Two Pathways That Are Similar to Those Required for
the Regulation of the Viral p5 Promoter
Nathalie Dutheil,* Sarah C. Smith, Leticia Agúndez, Zoé I. Vincent-Mistiaen, Carlos R. Escalante,* R. Michael Linden, Els Henckaerts
Department of Infectious Diseases, King’s College London School of Medicine, London, United Kingdom
ABSTRACT
Adeno-associated virus serotype 2 (AAV2) can efficiently replicate in cells that have been infected with helper viruses, such as
adenovirus or herpesvirus. However, in the absence of helper virus infection, AAV2 establishes latency by integrating its genome
site specifically into PPP1R12C, a gene located on chromosome 19. This integration target site falls into one of the most gene-
dense regions of the human genome, thus inviting the question as to whether the virus has evolved mechanisms to control this
complex transcriptional environment in order to facilitate integration, maintain an apparently innocuous latency, and/or estab-
lish conditions that are conducive to the rescue of the integrated viral genome. The viral replication (Rep) proteins control and
direct every known aspect of the viral life cycle and have been shown to tightly control all AAV2 promoters. In addition, a num-
ber of heterologous promoters are repressed by the AAV2 Rep proteins. Here, we demonstrate that Rep proteins efficiently re-
press expression from the target site PPP1R12C promoter. We find evidence that this repression employs mechanisms similar to
those described for Rep-mediated AAV2 p5 promoter regulation. Furthermore, we show that the repression of the cellular target
site promoter is based on two distinct mechanisms, one relying on the presence of a functional Rep binding motif within the 5=
untranslated region (UTR) of PPP1R12C, whereas the second pathway requires only an intact nucleoside triphosphate (NTP)
binding site within the Rep proteins, indicating the possible reliance of this pathway on interactions of the Rep proteins with
cellular proteins that mediate or regulate cellular transcription.
IMPORTANCE
The observation that repression of transcription from the adeno-associated virus serotype 2 (AAV2) p5 and integration target
site promoters is mediated by shared mechanisms highlights the possible coevolution of virus and host and could lead to the
identification of host factors that the virus exploits to navigate its life cycle.
Adeno-associated virus serotype 2 (AAV2) is a human DNAvirus that is dependent upon a number of factors provided by
helper viruses in order to replicate efficiently (1–4). In the absence
of helper factors, AAV2 has the ability to establish latency by site-
specifically integrating its genome into chromosome 19 (5, 6). A
complex interplay between host cellular, AAV2, and helper virus
proteins leads to the tight regulation of a life cycle that is unique
among eukaryotic viruses. The nonstructural proteins Rep78,
Rep68, Rep52, and Rep40, encoded by the AAV2 rep genes, play a
major role in orchestrating the different aspects of the AAV2 life
cycle. The large Rep proteins, Rep78 and Rep68, transcribed from
the p5 promoter, aremultifunctional proteins with DNA binding,
endonuclease, and helicase activities that control replication, in-
tegration, and transcription (reviewed in reference 7). The small
Rep proteins, transcribed from the p19 promoter, share the nu-
cleoside triphosphatase (NTPase) and helicase activity with the
large Rep proteins and are required for efficient packaging of the
viral particles (8). The Rep proteins have a distinctive autoregula-
tory role in that they control p5 and p19 transcription as well as
p40-controlled transcription of the structural proteins. In the
presence of helper virus, repression of the p5 promoter byRep and
cellular factors YY1 and MLTF is lifted (9–11), which leads to
transactivation of transcription from all three promoters (12) but
is regulated so that p40 transcript levels are higher than the p5 and
p19 transcript levels (13). Sequences within, as well as outside, the
viral promoter regions have been shown to be involved in Rep
activation (14). Interestingly, during productive infection, the
Rep proteins can mediate both activation and repression of tran-
scription (15). More specifically, the large Rep proteins activate
transcription from the p5 promoter through binding to the Rep
binding site (RBS) present in the inverted terminal repeat (ITR)
and mediate p5 repression by binding to the RBS in the p5 pro-
moter. This repression can be partially lifted by the small Rep
proteins and contributes to an autoregulatory loop, which main-
tains constant ratios of the p5 and p19 transcripts (16).
In the absence of helper virus, p5, p19, and p40 transcription is
significantly reduced, leading to minute levels of Rep protein ex-
pression (17–19). Rep-mediated repression of p5 transcripts ap-
pears to be dependent on the NTP-binding motif present in the
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central domain of the Rep proteins, as well as the presence of an
intact RBS motif in the p5 promoter (20). In contrast, Rep-medi-
ated repression of the p19 promoter requires only the NTP-bind-
ing motif of Rep (19). Transcriptional repression by Rep is not
exclusive to AAV2 promoters but has also been observed for het-
erologous promoters, such as theHIV long terminal repeat (LTR),
the human papillomavirus 18 (HPV18) upstream regulatory re-
gion (URR), and the major late transcription promoter of adeno-
virus (AdMLP), and is dependent on the Rep NTP-binding do-
main (21, 22). Rep also affects the expression of cellular genes,
such as those encoding c-myc and c-sis/platelet-derived growth
factor B (23–25); however, the significance of Rep-mediated reg-
ulation of these promoters in the context of AAV2’s life cycle has
yet to be established.
AAV2 has the ability to site-specifically integrate its genome
into a gene,PPP1R12C, that encodes a protein that is thought to be
a component of the regulatory subunit of myosin light chain
phosphatase (26). Analysis of the 5= untranslated region (UTR) of
this gene led to the observation that the minimal promoter region
of PPP1R12C and the p5 promoter have two important cis-regu-
latory elements in common, namely, the RBS and YY1 sites (27).
This observation, together with the fact that AAV2 establishes
latency by integrating into a ubiquitously transcribed locus, pro-
voked the question of whether AAV2 has evolved the ability to
control transcription of theAAV2 integration target locus in order
to aid the establishment of latency and secure viral rescue.
We demonstrate here that Rep proteins efficiently repress ex-
pression from the target site PPP1R12C promoter, employing
mechanisms similar to those described for Rep-mediated viral p5
promoter regulation. We provide evidence that the observed re-
pression is based on two distinct mechanisms: one relies on the
presence of a functional Rep binding motif within the 5= UTR of
PPP1R12C, whereas the second pathway requires only an intact
NTP-binding site within the Rep proteins, possibly indicating the
reliance of this pathway on interactions of the Rep proteins with
factors of or associated with the cellular transcription machinery.
We propose that the p5 promoter has coevolved with the host
PPP1R12C promoter, thereby ensuring the possibility that Rep
can control the expression at the viral integration site.
MATERIALS AND METHODS
Cell lines and viruses. HEK-293T/17 human embryonic kidney cells
(ATCC CRL-11268) and HeLa human cervical epithelial cells (ATCC
CCL-2) were cultured in Dulbecco’s modified Eagle’s medium (DMEM)
(Invitrogen) supplemented with 10% fetal bovine serum (FBS) (Invitro-
gen).
AAV2 and human adenovirus type 5 (Ad5) were produced and puri-
fied as previously described (28).
Infections. Cells were infected in 60-mm plates at 70% confluence by
adding increasing amounts of wild-type (wt) AAV2 (multiplicity of infec-
tion [MOI], 1 to 104 infectious units per cell) to 1 ml of DMEM and 10%
FBS. After 2 h of incubation at 37°C, 293T and HeLa cells were coinfected
with adenovirus type 5 at an MOI of 5 and 10 PFU, respectively. After 1 h
of incubation at 37°C, the inoculum was removed, and 3 ml of fresh
medium was added to the cells.
Reporter constructs. To increase the sensitivity of the reporter con-
struct, we replaced DsRed2.1 with mCherry in the previously used332/
94 plasmid (pND26). The plasmid contains the PPP1R12C promoter
region from nucleotides (nt) 332 to 94 relative to the transcription
start site (27).
The PPP1R12Cp-mCherry (pND203) reporter construct was cloned
in two steps. The mCherry open reading frame (ORF) was first amplified
by PCR using ND381 (5=GGATCCCACAACCATGGTGAGCAAGGGC-
3=) andND382 (5=-GCGGCCGCTACTTGTACAGCT-3=) as primers and
pTW149 as the template (28). The resulting PCR product was cloned into
pCR2.1 (Invitrogen) to create pND202. To generate the PPP1R12Cp-
mCherry (pND203) and p5-mCherry (pND208) reporter constructs, the
mCherry sequence linked to a BamHI/NotI fragment from pND202 was
subcloned into the BamHI/NotI-digested pND26 and p5 vectors
(pND85), respectively (27). The p5-mCherry construct contains the p5
promoter region (nt 190 to nt 310 relative to the AAV2 sequence) de-
scribed by Cheung et al. (29).
Mutations within the PPP1R12C RBS were introduced by inserting
annealed primers into the BamHI/SmaI sites of the pND23 plasmid (the
PPP1R12Cpromoter region fromnt332 to20 cloned into pBluescript
II SK [Fermentas]) (27). The resulting plasmid, pND31 (the PPP1R12C
promoter region from nt 332 to 94), was digested with BamHI and
HindIII, and the PPP1R12C promoter fragment containing the mutated
RBS motif was blunt ended prior to ligation into the SmaI site of the
pDsRed2.1 vector (Clontech) to create plasmid pND34 (PPP1R12Cp-
RBS*-DsRed2.1). To generate the PPP1R12Cp-RBS*-mCherry reporter
construct (pND212), the mCherry-containing BamHI/NotI fragment
from pND202 was subcloned into the BamHI/NotI sites of the pND34
plasmid. The same mutation was introduced into the p5 RBS by site-
directed mutagenesis on the pND84 (p5-pCR2.1) template (27) to create
pND235. To generate the p5-RBS*-mCherry construct (pND236), the
SmaI fragment containing the p5 promoter region from pND235 was
inserted into the SmaI sites of pND208.
To generate the pEGFP-PPP1R12Cp-mcherry bidirectional promoter
construct (pND238), the blunt-endedAflII/MscI enhanced green fluores-
cent protein (EGFP)-encoding fragment of pIRES2-EGFP (Clontech) was
subcloned into the blunt-ended EcoRI site of pND203.
Rep-expressing constructs. All Rep-expressing constructs were
cloned into the pIRES2-EGFP vector. To generate the Rep78-expressing
plasmid (pR78-IRES2-EGFP), the Rep78-encoding DraI/SphI fragment
from plasmid pHis-Rep78 (30) was first ligated to annealed adaptors and
inserted between the SmaI and NheI sites of the pIRES2-EGFP vector. To
generate pR78Y156F-IRES2-EGFP, the SacII/SalI fragment containing
the Y156F mutation from plasmid pHis-Rep68Y156F (30) was cloned
into the SacII/SalI-digested pR78-IRES2-EGFP vector. To generate
pRep68Y156F-IRES2-EGFP (pND21), the BamHI fragment of pHis-
Rep68 (31) containing the C-terminal region of Rep68 was inserted be-
tween the BamHI sites of pR78Y156F-IRES2-EGFP. The initiationmethi-
onine of Rep52 and Rep40 was mutated to a glycine (M225G) by site-
directed mutagenesis. The resulting PCR fragment was cloned into the
pCR2.1 vector to generate pND102. The SacI/SalI fragment containing
the M225G mutation from pND102 was inserted into the corresponding
SacI/SalI fragment of pRep78Y156F-IRES2-EGFP and pND21 to generate
pR78Y156F/M225G-IRES2-EGFP (pND105) and pR68Y156F/M225G-
IRES2-EGFP (pND104), respectively.
The 5= ends of Rep52 and Rep40 were generated by PCR on a pAV2
template with primers ND144 (5=-GATATCGCACAACATGGAGCTGG
TCGGG-3=) and ND67 (5=-CATCCGGTCTTGCAACGGCTGC-3=), and
the resulting PCR product was subcloned into the pCR2.1 cloning vector
to create pND20. pRep52-IRES2-EGFP (pND22) was constructed by in-
serting the 5= end of Rep52 containing the EcoRV/SalI fragment from
pND20 into the EcoRV/SalI sites of pRep78Y156F-IRES2-EGFP. To gen-
erate pRep40-IRES2-EGFP (pND56), the Rep40 3=-end BamHI fragment
from pND21 was inserted into the BamHI sites of pND22.
One, two, or three copies of the simian virus 40 (SV40) large T antigen
nuclear localization signal (NLS), PKKKRKV, were added in frame to the
3= end of the N208 open reading frame. PCR fragments amplified on
pRep78Y156F-IRES2-EGFP with primers containing the NLS sequences
were subcloned into pCR2.1 to generate pND59 (pN208Y156F-NLS1)
and pND75 (pN208Y156F-NLS2). pND81 (pN208Y156F-NLS3) was
generated by PCRon a pND75 template. To generate pN208Y156F-NLS1-
IRES2-EGFP (pND62), pN208Y156F-NLS2-IRES2-EGFP (pND82#2),
Dutheil et al.
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and pN208Y156F-NLS3-IRES2-EGFP (pND82#3), the PstI/BamHI frag-
ment containing the 3= end of N208 from pND59, pND75, and pND81
was inserted into the corresponding PstI/BamHI sites of pRep78Y156F-
IRES2-EGFP.
To generate pRep68Y156F/K340H-IRES2-EGFP (pND25), the SacI/
AccI fragment of pHis-Rep68K340H (32, 33), containing the K340Hmu-
tation, was inserted between the SacI/AccI sites of pND21. pRep68Y156F/
M225G/K340H-IRES2-EGFP (pND140) and pRep40/K116H-IRES2-
EGFP (pND80) were generated by inserting the BamHI fragment from
pND25, containing the K340Hmutation, into the corresponding BamHI
fragments from pND104 and pND56. pRep78Y156F/M225G/K340H-
IRES2-EGFP (pND146) and pRep52K116H-IRES2-EGFP (pND143)
were generated by inserting a fragment containing the K340H mutation
frompND140 (SacI/AccI) and pND80 (EcoRV/SalI) into the correspond-
ing sites of pRep78Y156F-IRES2-EGFP.
Todelete the internal ribosomeentry site 2 (IRES2)-EGFP sequence from
Rep-expressing vectors andgeneratepIRES2-EGFP(pND216), theplasmid
pIRES2-EGFP was digested with BamHI and NotI, and the overhangs were
blunt endedwith theKlenowDNApolymeraseprior to religation.TheRep78
and Rep68 ORFs were amplified by PCR from the pND105 and pND104
plasmids using the SmaI-containing primers ND387 (5=-CCCGGGATATC
GCACAACATGCCGGGG-3=) and ND388 (5=-CCCGGGTTATTGTTCAA
AGATGCAGTCATCCAAATC-3=), andND387andND389(5-CCCGGGT-
CAGAGAGAGTGTCCTCGAGC-3=), respectively. The resulting PCR
fragments were subcloned into the PCR2.1 cloning vector to generate
pND221 (Rep78Y156F/M225G-pCR2.1) and pND220 (Rep68Y156F/
M225G-pCR2.1). pRep78Y156F/M225G-EGFP (pND227) and pRep
68Y156F/M225G-EGFP (pND226) were generated by subcloning the Rep-
encoding SmaI fragment from pND221 and pND220 into the SmaI site of
pND216. pRep52-EGFP (pND230) and pRep40-EGFP (pND229) were
generated by inserting the 5= ends of the Rep52 and Rep40 EcoRV/BstEII
fragments from pND22 and pND56 into the EcoRV/BstEII sites from
pND227 and pND226, respectively. Plasmids pRep78Y156F/M225G/
K340H-EGFP (pND231), pRep68Y156F/M225G/K340H-EGFP
(pND232), pRep52K116H-EGFP (pND233), and pRep40K116H-EGFP
(pND234)were generated by inserting the EcoRV/BstEII fragments contain-
ing the K340H mutation from plasmids pND146, pND140, pND143, and
pND80 into the corresponding EcoRV/BstEII sites of plasmids pND227,
pND226, pND230, and pND229. All the vectors were sequenced.
Transient transfections. Transient transfections were performed in
60-mm plates using Lipofectamine 2000 according to the manufacturer’s
instructions (Invitrogen). At 70% confluence, 293T cells were transfected
with 4.5g of reporter plasmid and 9g of Rep-expressing plasmid. Cells
were harvested 48 h posttransfection and assayed for plasmidDNAuptake
and RNA and protein levels.
Plasmid uptake determination.The transfected cells were lysed in 0.2
M NaOH and 10 mM EDTA, boiled for 15 min at 90°C, and loaded onto
a Hybond nitrocellulose membrane (Amersham) using a slot blot mani-
fold (Bio-Rad). The membranes were hybridized to mCherry or EGFP
probes to estimate the amount of reporter plasmid taken up by the cells.
The probes were generated by PCR using 5=-GGATCCCACAACCATGG
TGAGCAAGGGC-3= and 5=-GCGGCCGCTACTTGTACAGCT-3= for
mCherry and 5=-GCTAGCCACAACCATGGTGAGCAAGGGC-3= and
5=-GCTAGCTTACTTGTACAGCTCGTCCATGCCG-3= for EGFP.
Transfection efficiencies were normalized to plasmid reporter uptake.
Real-time qRT-PCR. Total RNA was extracted with the RNeasy kit
(Qiagen) and reverse transcribed using SuperScriptIII reverse transcrip-
tase (RT) (Life Technologies). Real-time quantitative RT-PCR (qRT-
PCR) was performed on 50 to 100 ng cDNA using TaqMan Gene Expres-
sion Assays for ACTB (Hs99999903_m1) and PPP1R12C (Hs01085952_
m1) andTaqManUniversal PCRmastermix (Life Technologies). Relative
expression levels were determined by the comparative threshold cycle (Ct)
method (34).
Northern blot analysis. Total RNA was extracted with the RNeasy kit
(Qiagen). Tenmicrograms (infected cells) or 2g (transiently transfected
cells) of RNA was separated on a 1.2% formaldehyde-agarose gel and
transferred onto a nitrocellulose membrane. The membranes were first
hybridized to [-32P]dCTP-labeled mCherry, PPP1R12C (exons 18 to
22), rep, or GFP probes; stripped at 65°C in 50% formamide, 2 SSC (1
SSC is 0.15 M NaCl plus 0.015 M sodium citrate); and rehybridized to a
-actin cDNA probe. The PPP1R12C and -actin cDNA probes were
generated as described byDutheil et al. (27). ThemCherry andGFP cDNA
probes were generated by PCR using the primers mentioned above. The
rep probe was generated by PCR on a plasmid containing a 315-bp PstI/
SacI fragment from pAV2 using 5=-GGATCCTCAATTCTGATTCTCTT
TG-3= and 5=-CCCGGGGGTCCTGTATTAGAGGTCACGTG-3=. All
Northern blots were analyzed with a Typhoon PhosphorImager (Molec-
ular Dynamics) and then exposed to an X-ray film to generate high-qual-
ity images. ImageQuant TL software was used to calculate fold repression.
Each average repression level is represented as the mean and standard
error of the mean (SEM).
Western blot analysis. Forty-eight hours after transfection, cells were
lysed in RIPA buffer (50 mMTris-HCl [pH 8], 150 mMNaCl, 0.1% SDS,
1% Nonidet P-40, 0.5% sodium deoxycholate, 1 Complete protease
inhibitor cocktail [Roche Applied Science]), and proteins were quantified
by the bicinchoninic acid (BCA) protein assay (Pierce). For each condi-
tion, the same amount of protein (10 g) was separated on a 15% SDS-
polyacrylamide gel and transferred to a nitrocellulose membrane (Hy-
bond-C Extra nitrocellulose; Amersham Biosciences). The membranes
were blocked with 5% nonfat dry milk in Tris-buffered saline (TBS) (100
mM Tris-Cl, pH 7.5, 150 mMNaCl) containing 0.5% Tween 20 (TBS-T)
for 1 h at room temperature and incubated with primary antibody over-
night at 4°C. Themembranes were washed in TBS-T buffer (three 15-min
washes) and then incubated with secondary antibody conjugated to
horseradish peroxidase for 1 h at room temperature. After three washes in
TBS-T buffer, the membranes were developed using enhanced-chemilu-
minescence (ECL) substrate (Pico detection kit; Pierce). Using an Im-
ageQuant LAS 4000 Biomolecular Imager and ImageQuant software (GE
Healthcare Life Sciences), band densitometry was performed, and the
result was normalized against the value of actin protein expression. After
visualization of the desired protein, the membranes were stripped in Re-
store Western blot stripping buffer (Pierce) for 30 min at room tempera-
ture. The membranes were washed four times in TBS-T buffer, blocked
with 5% nonfat dry milk, and then hybridized with specific antibody.
The primary antibodies used in the study were antibodies against
mCherry (1:16,000 dilution in 1% bovine serum albumin [BSA] in
TBS-T; Clontech; rabbit polyclonal red fluorescent protein [RFP] anti-
body; catalog no. 632397); GFP (1:5,000 dilution in 5% milk in TBS-T;
Roche Applied Science; mouse monoclonal GFP antibody; catalog no. 11
814 460 001); AAV2Rep proteins Rep78, Rep68, Rep52, andRep40 (1:100
dilution in 5% nonfat dry milk–PBS-T for monoclonal antibody clone
303.9 [Progen Biotechnik catalog no. 61069] or 1:500 dilution in 1%
BSA–PBS-T for monoclonal antibody clone 226-7 [Acris Antibodies cat-
alog no. BM5012SU]); AAV-2 Rep proteins Rep78, Rep68, and Rep78-
N208 (1:200,000 dilution in 5% nonfat dry milk–PBS-T; rabbit poly-
clonal anti-N208 antibody); and actin proteins (1:10,000 dilution in 5%
nonfat dry milk in PBS-T; BD Biosciences; mouse monoclonal actin an-
tibody; catalog no. 612656). Polyclonal anti-N208 antibodywas produced
in rabbits immunizedwith the truncated Rep protein Rep78-N208, con-
taining the first N-terminal 208 amino acids of Rep78 and Rep68 (Co-
calico Biologicals Inc.).
Goat anti-mouse (Jackson ImmunoResearch Laboratories; catalog no.
115-035-003) or anti-rabbit (Jackson ImmunoResearch Laboratories;
catalog no. 111-036-003) secondary antibody conjugated to horseradish
peroxidase was used at a dilution of 1:10,000 in 5% nonfat dry milk in
PBS-T.
Each average repression level is represented as the mean and SEM.
Immunofluorescence. HeLa cells were grown in 24-well plates on
coverslips coated with poly-L-lysine. At 50% confluence, the HeLa cells
were transfected with 0.75 g of DNA using the Lipofectamine Plus re-
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agents (Invitrogen). The cells were fixed 48 h posttransfection in cold
acetone, permeabilized with 0.1% Triton X-100 for 5 min, and blocked in
5%normal goat serumovernight. The slides were incubated with primary
rabbit anti-N208 antibody (1:1,000 dilution in PBS) for 1 h at room tem-
perature, washed in PBS, and incubated with a Cy3 goat anti-rabbit anti-
body (1:1,000 dilution in PBS; Jackson ImmunoResearch; catalog no. 711-
165-152) for 1 h at room temperature. The slides were subsequently
washed in PBS and mounted in Vectashield Mounting Medium contain-
ing DAPI (4=,6-diamidino-2-phenylindole; Vector Laboratories). Images
were acquired at100 magnification using a Leica DMRA2 fluorescence
microscope with a Hamamatsu charge-coupled-device (CCD) digital
camera and analyzed with Openlab software (Improvision).
Fluorescence-activated cell sorting.Todetermine the effect ofRepon
endogenous PPP1R12C expression, 293T cells transfected with the differ-
ent Rep-IRES-GFP expression constructs were harvested 48 h posttrans-
fection and sorted for GFP expression using the BD FACSAria II (Becton
Dickinson) prior to RNA isolation.
RESULTS
Under permissive conditions, AAV2 infection leads to down-
regulation of PPP1R12C expression. To determine if AAV2 in-
fection leads to changes in the expression levels of the target site
PPP1R12C promoter, 293T and HeLa cells were infected with wt
AAV2 using increasing MOIs in the presence and absence of
adenovirus (wt Ad5). Coinfection with adenovirus leads to
permissive conditions, which support efficient AAV2 replication,
whereas infection with AAV2 alone represents nonpermissive
conditions under which the virus can establish latency. Total RNA
was extracted 48 h postinfection (p.i.), and the expression of
PPP1R12Cwas analyzed byNorthern blotting and real-time qRT-
PCR. In the absence of adenovirus infection, expression levels of
PPP1R12C were similar in control and wt AAV2-infected HeLa
cells at all MOIs tested (Fig. 1A, top right). In 293T cells, the same
tendency was observed; however, at higher MOIs, slightly lower
levels of PPP1R12C expression were observed than in control cells
(Fig. 1A, top left). In contrast to nonpermissive conditions,
PPP1R12C expression is clearly repressed in wt AAV2- and ade-
novirus-coinfected cells compared to control cells, and this was
observed for both cell lines (Fig. 1A, top row). Importantly, this
effect does not appear to be mediated by adenovirus alone, as
PPP1R12C expression levels were similar in control and adeno-
virus-infected cells. Note that the actin expression levels re-
mained unaltered upon productive AAV2 infection. The ob-
served repression of PPP1R12C expression under permissive
conditions was confirmed by real-time qRT-PCR (Fig. 1B).
As the large Rep proteins, Rep78 and Rep68, are highly ex-
pressed under permissive conditions, we determined whether
downregulation of PPP1R12C expression might be related to the
presence of Rep78 or Rep68 (Rep78/Rep68) transcripts (12). As
expected, the AAV2 p5 transcripts can be detected in AAV2- and
adenovirus-coinfected cells, whereas Rep78/Rep68 expression
cannot be detected in AAV2- or adenovirus-infected or control
cells (Fig. 1A, middle row). These data indicate that a decrease in
PPP1R12C expression might be correlated with an increase in p5
FIG 1 PPP1R12C and rep expression levels in AAV2-infected cells. (A) Representative example of Northern blot analysis of 293T (left) and HeLa (right) cells
infected with wt AAV2 at increasing MOIs (1 to 10,000) in the absence (Ad) and presence (Ad) of adenovirus 48 h postinfection. Northern blots were
hybridized with PPP1R12C (top), p5-Rep (middle), and -actin (bottom) cDNA probes. Relative fold repression of PPP1R12C expression is indicated at the
bottom. (B) Determination of PPP1R12C expression levels by real-time qRT-PCR in the samples shown in panel A confirms downregulation of PPP1R12C
expression during productive AAV2 infection in two different cell lines.
Dutheil et al.
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transcript levels, suggesting that the AAV2 Rep proteins canmod-
ulate PPP1R12C expression within its genomic locus. It is inter-
esting that in 293T cells, despite the decrease of Rep transcript
levels at higher MOIs, PPP1R12C expression levels remain
strongly repressed.
A potential link between downregulation of expression from
theAAV2 integration target site promoter andRep expressionwas
further supported by a time course experiment of AAV2 and ad-
enovirus infection in 293T cells, for which PPP1R12C and Rep
expression levels were determined by real-time qRT-PCR. The
presence of Rep proteins in AAV2- and adenovirus-coinfected
cells was confirmed byWestern blotting. Twenty-four hours after
infection, we could observe a modest decrease in relative
PPP1R12C expression levels in cells coinfected at a highMOI (Fig.
2A, left), which became more pronounced at later time points
(Fig. 2A and B, left). At 48 h postinfection, we could also observe
downregulation of expression in the absence of adenovirus. Inter-
estingly, Rep transcripts were detected under all conditions but
increased strongly when adenovirus was added to the cultures. In
general, Rep transcript levels decreased as the infection pro-
gressed. Western blot analysis of the samples showed strong ex-
pression of the large Rep proteins 24 h after coinfection, increas-
ing expression of the small Rep proteins at 30 h postinfection, and
decreasing Rep protein levels at 48 h postinfection (Fig. 2A, B, and
C, right).
Both large and small Rep proteins repress PPP1R12C pro-
moter activity. In order to test whether the observed repression is
directly mediated by the viral Rep proteins, we transfected 293T
cells with different Rep expression constructs. Since the chromo-
somal RBS and terminal resolution site (TRS) are located in the 5=
UTR of the PPP1R12C gene (27), it is conceivable that Rep78 and
Rep68 can interfere with the PPP1R12C promoter activity by in-
troducing a site-specific nick in the 5=UTR (35, 36). Therefore, all
experiments were executed using the Rep mutant RepY156F,
which lacks nicking enzymatic activity (37) (Fig. 3A). Since the
Rep52 and Rep40 proteins are the N-terminally truncated forms
of Rep78 and Rep68, respectively, the initial methionine of Rep52
and Rep40 was mutated to a glycine to accomplish expression of
the large Rep proteins only (20, 21) (Fig. 3A). We also examined
whether the truncated protein containing only the first N-termi-
nal 208 amino acids of Rep, Rep78-Y156F-N208, could affect
PPP1R12C promoter activity. The rationale for using the Rep78-
Y156F-N208protein is that this truncated protein has previously
been shown to be the minimal domain that can efficiently bind to
both AAV2 and PPP1R12C RBS sequences in vitrowhile retaining
its TRS endonuclease activity (30). Because Rep78-Y156F-N208
lacks the bipartite NLS, which is localized in the C-terminal do-
main of Rep78/Rep68 (38), the C-terminal region of Rep78-
Y156F-N208 was fused to either one, two, or three tandem re-
peats of the NLS of SV40 large T antigen. In order to assess
whether Rep78-Y156F-N208 is effectively translocated to the
nucleus, we performed immunofluorescence microscopy on cells
transfectedwith the differentNLS constructs. As shown in Fig. 3B,
Rep78-Y156F-N208 containing three copies of the SV40 large T
antigen NLS is, like wild-type Rep78, mainly located in the nu-
cleus. Rep78-Y156F-N208 containing only one or two copies of
the SV40 large T antigen NLS is predominantly located in the
cytoplasm and in the perinuclear region (data not shown). All Rep
variants were cloned into an IRES-GFP vector. The transfected
cells were sorted forGFP expression to ensure the presence of Rep.
As shown in Fig. 3C, all Rep proteins except Rep78-Y156F-N208
had the ability to strongly repress endogenous PPP1R12C expres-
sion levels in GFP-positive cells (Fig. 3C). Western blot analysis
confirmed expression of the different Rep proteins in the trans-
fected cells (Fig. 3D).
In order to obtain better insight into potential mechanisms
responsible for the observed Rep-mediated repression of
PPP1R12C expression, we cotransfected Rep constructs (Fig. 3A)
with reporter constructs containing the mCherry gene under the
control of the PPP1R12C or AAV2 p5 promoter (Fig. 4A). Since
Rep proteins can modulate the expression of a number of cellular
and viral genes, including the cytomegalovirus (CMV) promoter
(23, 24, 39), it is not possible to correct for variations in transfec-
tion efficiency by normalization to the activity of a cotransfected
plasmid expressing a marker gene under the control of a viral or
eukaryotic promoter. Therefore, transfection efficiencies were
normalized to plasmid DNA uptake, as described previously (39).
Figure 4B shows a representative example of the Northern and
Western blot analyses performed. Transcript and protein levels
from three independent experiments are shown in Fig. 4C. Rep78
and Rep68 strongly inhibit PPP1R12C promoter-driven expres-
sion at both the RNA and protein levels. In contrast to the large
Rep proteins, Rep52 and Rep40 reproducibly inhibit PPP1R12C
promoter activity, but at lower levels. Changes in RNA levels par-
allel those observed for protein levels. These data demonstrate that
all Rep proteins have the ability to mediate repression of the
PPP1R12C promoter despite significant differences in the levels of
inhibition between Rep78/Rep68 and Rep52/Rep40. The differ-
ence in ability to repress PPP1R12C expression between the small
and large Rep proteins was not as evident with the endogenous
gene, which can be explained by a lower gene copy number than in
the overexpression system. Similarly to what is shown in Fig. 3C,
the level of PPP1R12C expression in the presence of Rep78-
Y156F-N208 is comparable to that detected in the absence of
Rep (Fig. 4B and C). These data indicate that Rep78-Y156F-
N208 does not have the ability to regulate PPP1R12C promoter
activity, suggesting that the DNA binding domain is not sufficient
to inhibit PPP1R12C expression.
As the AAV2 p5 promoter shares common regulatory elements
with the PPP1R12C promoter (27), the question arises as to
whether the viral Rep proteins might regulate the two promoter
activities by similar mechanisms. Therefore, we compared Rep’s
effects on the p5 and PPP1R12C promoters. Interestingly, all Rep
proteins downregulate the AAV2 p5 promoter similarly to what
we observed for the PPP1R12C promoter (Fig. 4B andC, right). In
agreement with previously published data (19), the large Rep pro-
teins completely repress p5 promoter activity, whereas the small
Rep proteins inhibit the p5 promoter to a lesser extent. Of note,
Rep78-Y156F-N208moderately represses p5 transcriptional ac-
tivity, whereas the PPP1R12C promoter activity remains relatively
unchanged in the presence of this truncated Rep protein.
The NTP-binding motif is required for Rep52- and Rep40-
mediated repression of the p5 andPPP1R12C promoters.Previ-
ous studies established that a residue within the NTP-binding do-
main of Rep78 (K340) is critical for the negative regulation of the
p19, HIV LTR, and HPV18 URR promoters (21), raising the hy-
pothesis that the same residue might be required for PPP1R12C
promoter repression. As Rep52 and Rep40 mainly consist of an
NTP-binding domain with ATPase and helicase activities (Fig.
5A), we used the smaller Rep proteins to determine whether mu-
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tations in the NTP-binding motif would have an effect on
PPP1R12C and p5 promoter activities. To address this, wild-type
or mutant Rep proteins were cotransfected with the PPP1R12C or
p5 reporter construct. Northern and Western blot analyses were
performed to determine RNA and protein expression levels, re-
spectively (Fig. 5B). Transcript and protein levels from 3 indepen-
dent experiments are shown in Fig. 5C. Similar to the data pre-
sented in Fig. 4B and C, wt Rep52 and wt Rep40 moderately
inhibit the PPP1R12C and p5 promoter activity, as seen for RNA
and protein levels (Fig. 5B and C). In contrast to the wt Rep pro-
FIG 2 Time course of PPP1R12C and rep expression levels in AAV2-infected 293T cells. (A to C, left) Determination of PPP1R12C expression levels by real-time
qRT-PCR in 293T cells 24 (A), 30 (B), and 48 (C) hours after AAV2 infection (at increasing MOIs in the absence and presence of adenovirus). Relative fold
repression of PPP1R12C expression is indicated at the bottom. (A to C, top right) Determination of rep expression levels by real-time qRT-PCR in 293T cells 24
(A), 30 (B), and 48 (C) hours after AAV2 infection (at increasing MOIs in the absence and presence of adenovirus). Relative expression levels were determined
in 2 independent infection experiments at each time point. (A toC, bottom right) Representative example ofWestern blot analysis of Rep expression in 293T cells
24 (A), 30 (B), and 48 (C) hours after AAV2 infection.
Dutheil et al.
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teins, the mutant Rep52-K116H and Rep40-K116H proteins,
which harbor a mutation that corresponds to the K340H muta-
tion in the large Rep proteins, have no clear effect on PPP1R12C
and p5 promoter activity (Fig. 5B and C). The relief of repression
by the NTP-binding mutants is not due to differences in protein
expression levels, as they are similar for all Rep constructs, or even
slightly higher for the Rep40-K116H mutant than for the corre-
sponding wt protein, as indicated by Western blotting. In sum,
these data demonstrate that Rep52 and Rep40 inhibit the
PPP1R12C and p5 promoter activities in a similar manner and
that this repression requires the consensus NTP-binding motif.
The RBS and the NTP-binding motif are both required for
Rep78/Rep68-mediated repression of the p5 and PPP1R12C
promoters.We next investigated the mechanism by which Rep78
and Rep68 mediate PPP1R12C repression. Since the AAV2 Rep78
and Rep68 proteins have the ability to bind to the RBS located
within the 5= UTR of the PPP1R12C gene (36), we hypothesized
that, as observed for the repression of the p5 promoter (20), direct
interaction of Rep with the RBS might also be involved in the
inhibition of PPP1R12C. To address this, we used a reporter con-
struct containing a mutation within the RBS that abolishes Rep
binding to the RBS in the PPP1R12C promoter (36). We intro-
duced the same mutation in the p5 RBS. Transcript and protein
levels from 3 independent experiments were quantitated (Fig.
6C), and a representative example is shown in Fig. 6B. Similarly to
what is shown in Fig. 4, Rep78- and Rep68-expressing plasmids
strongly repress PPP1R12C and p5 promoter activities (Fig. 6B
and C). Compared to the wt promoters, the mutation within the
RBS motif reduces the ability of Rep78 and Rep68 to decrease the
levels of PPP1R12C and p5 promoter transcripts (Fig. 6B and C).
Although Rep’s repressive effect on the mutant promoter is par-
tially relieved, it is still clearly present. These data indicate that a
direct interaction of Rep with the RBS is not sufficient to direct
Rep-mediated repression of the PPP1R12C promoter, suggesting
the existence of at least one additional mechanism at the basis of
the observed phenomenon. It has previously been shown that
Rep78 and Rep68 inhibit transcription from the p5 promoter by
two different mechanisms. The first mechanism requires direct
interaction of Rep with the RBS, while the second mechanism
depends on the presence of a functional NTP-binding motif (20).
We therefore tested the effects of the Rep78 and Rep68 nicking-
and NTP-binding-negative mutant proteins (Rep78-Y156F-
FIG 3 Endogenous PPP1R12C expression levels in Rep-transfected cells. (A) Schematic representations of the large (Rep78/Rep68), small (Rep52/Rep40), and
truncated (N208) Rep proteins used for overexpression in 293T cells. At the top are shown the different functional domains present in Rep78. Nucleotide
positions indicating the beginning and end of each domain are indicated above. The black bar shows the position of the NLS. Below are shown the large Rep
proteins, Rep78 and Rep68, used for the analysis. Mutations were introduced to avoid endonuclease activity (Y156F) and simultaneous expression of the small
Rep proteins (M225G). At the bottom are depicted the small Rep proteins (Rep52 and Rep40) and the N-terminally truncated Rep protein fused to 3 tandem
repeats of the SV40 large T antigen NLS (N208-NLS3). The different Rep proteins were expressed from CMV promoter-IRES-GFP vectors. (B) Epifluorescence
microscopy images of cells transfected with plasmids expressing Rep78-Y156F-N208 containing three copies of the SV40 large T antigen NLS and stained with
DAPI and anti-Rep (-Rep) (N208) antibody. The positive control consisted of cells transfected with a plasmid expressing full-length Rep78-Y156F; the negative
control consisted of cells transfected with the CMVpromoter-IRES-GFP vector. The images were taken at100magnification. (C)Determination of PPP1R12C
expression levels by real-time qRT-PCR in cells transfected with the different Rep constructs and sorted by fluorescence-activated cell sorter (FACS) for GFP
expression. Relative expression levels were determined in 3 independent transfection experiments. The error bars indicate SEM. (D) Western blot analysis
confirmed the presence of the respective Rep proteins in the transfected cells.
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K340H and Rep68-Y156F-K340H) (Fig. 6A) on the wt and mu-
tated PPP1R12C and p5 promoters. As shown in Fig. 6B and C
(left), in the presence of an unaltered RBS, mutant Rep78/Rep68
proteins have a moderate repressive effect on the PPP1R12C pro-
moter activity. This effect can also be observed for protein levels.
Interestingly, the introduction of a mutation in the NTP-binding
motif did not affect the repression of p5 transcription levels, as
previously observed (19); however, a change in p5 repression was
clear at the protein level (Fig. 6B and C, right). These results indi-
cate that the activity of the NTP-binding motif in Rep78/Rep68 is
FIG 4 Analysis of the effects of the four AAV2 Rep proteins on PPP1R12C promoter (PPP1R12C p)- and AAV2 p5-directed gene expression. (A) Schematic
representations of the AAV2 p5 and PPP1R12CmCherry reporter plasmids. The genomic structures of the Rep and PPP1R12C genes are depicted at the top. The
bent arrowsmark the p5 and PPP1R12C transcription start sites (TSS). The white boxes indicate the positions of the p5 RBS and PPP1R12CTRS-RBSmotifs. (B)
Northern blot analysis shows PPP1R12C (left) and p5 (right) transcription levels in 293T cells cotransfected with an mCherry reporter plasmid and the
Rep-expressing plasmids shown in Fig. 3A. The blots were stripped and hybridized with a-actin cDNAprobe (lower blots). Relative fold repression ofmCherry
expression is indicated below the blots. Western blot analysis shows the corresponding mCherry protein levels resulting from PPP1R12C (left) and p5 (right)
promoter activity. Rep expression was confirmed by Western blotting using the 226-7 and N208 antibodies. The blots were also incubated with a -actin
antibody, and relative fold repression was determined (indicated below the blots). Slot blot membranes hybridized to an mCherry probe show similar plasmid
uptake for all experimental conditions. (C) Determination of average mCherry expression levels from the PPP1R12C (left) and p5 (right) promoters from 3
independent experiments by Northern andWestern blot analyses. Average fold repression of mCherry expression is indicated at the bottom of each graph. The
error bars indicate SEM.
FIG 5 Analysis of the effects of the Rep52/Rep40 proteins and corresponding NTP-binding mutants on gene expression from the PPP1R12C and p5 promoters.
(A) At the top are shown the different functional domains present in Rep78. Nucleotide positions indicating the beginning and end of each domain are indicated
above. The black bar shows the position of theNLS. Below are shown schematic representations of the various small Rep proteins coexpressedwith thePPP1R12C
and p5 mCherry reporter plasmids. The NTP-binding mutants harbor a mutation at amino acid position 116 (K116H). (B) Northern blot analysis shows
PPP1R12C (left) and p5 (right) transcription levels in 293T cells cotransfectedwith anmCherry reporter plasmid and various Rep-expressing plasmids. The blots
were stripped and hybridized with a -actin cDNA probe (lower blots). Relative fold repression of the mCherry transcription levels is indicated at the bottom of
the blots. Western blot analysis shows the corresponding mCherry protein levels resulting from PPP1R12C (left) and p5 (right) promoter activity (top).
Expression of the small Rep proteins and NTP-binding mutants was determined by hybridization with the 226-7 antibody. The blots were also incubated with
a -actin antibody, and relative fold repression was determined (indicated below the blots). Slot blot membranes hybridized to an mCherry probe show similar
plasmid uptake for all experimental conditions. (C) Determination of average mCherry expression levels from the PPP1R12C (left) and p5 (right) promoters
from 3 independent experiments by Northern and Western blot analyses. Average fold mCherry repression is indicated at the bottom of each graph. The error
bars indicate SEM.
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FIG 6 Analysis of the effects of the Rep78/Rep68 proteins and corresponding NTP-binding mutants on gene expression from wild-type and RBS mutant
PPP1R12C and p5 promoters. (A) At the top are shown the different functional domains present in Rep78.Nucleotide positions indicating the beginning and end
Dutheil et al.
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not sufficient to accomplish complete PPP1R12C and p5 pro-
moter repression. Therefore, we investigated whether the Rep78/
Rep68 NTP-binding mutant proteins in the context of the mu-
tated PPP1R12C and p5 promoters would lead to the complete
abolishment of Rep78/Rep68’s repressive effects. In contrast to
the Rep78/Rep68-expressing plasmid, the NTP-binding-negative
mutant was unable to repress transcription from the PPP1R12C
and p5 promoters containingmutations in the RBSmotif (Fig. 6B
and C). Our data are in agreement with previously published re-
sults on Rep68-mediated repression of the p5 promoter (20).
Taken together, our data provide strong evidence that Rep78/
Rep68 exerts its negative regulatory effect on the PPP1R12C and
p5 promoters by identical mechanisms. Rep-mediated repression
of the p5 and PPP1R12C transcriptional activities requires, in ad-
dition to the NTP-binding motif, direct binding of Rep78/Rep68
to the RBS located within the promoter.
Rep-mediated repression of the antisense promoter requires
only a functional NTP-binding motif. We have previously re-
ported that the PPP1R12C promoter displays bidirectional pro-
moter activities (27). The ability of Rep to regulate PPP1R12C
transcription raises the question as to whether Rep is also able to
regulate the transcriptional activity of the antisense PPP1R12C
promoter. To address this question, the wt PPP1R12C promoter
fragment used in the PPP1R12Cp-mCherry reporter construct,
which exhibits both sense and antisense promoter activities (27),
was cloned into a dual-reporter construct carrying the mCherry
and EGFP genes in opposite directions. The PPP1R12C promoter
drives the expression of mCherry, while the antisense promoter
drives the expression of the EGFP cDNA. In order to simultane-
ously compare the effects of Rep on PPP1R12C sense and anti-
sense promoter activities, the EGFP cDNA was deleted from all
Rep-expressing constructs.
293T cells were transiently cotransfected with the PPP1R12C
bidirectional reporter vector and various Rep-expressing con-
structs. In the first set of experiments, we investigated the effects of
wt and NTP-binding mutant proteins on PPP1R12C promoter
activity in the context of the bidirectional construct (Fig. 7A).
Similarly to what is shown in Fig. 4, Rep78 and Rep68 strongly
repress PPP1R12C transcription from the bidirectional promoter,
whereas Rep52 and Rep40 moderately repress the levels of
PPP1R12C transcripts (Fig. 7B andC,mCherry). In contrast to the
wt Rep proteins, Rep78/Rep68 and Rep52/Rep40 NTP-binding
mutants exert different effects on the regulation of PPP1R12C
promoter activity. Rep78 and Rep68 mutant proteins moder-
ately repress the level of transcription, while the Rep52/Rep40
mutant proteins do not exhibit any negative regulatory effect
on PPP1R12C promoter activity (Fig. 7B and C, mCherry).
Similar observations were made for protein levels (Fig. 7B and
C, mCherry).
Having validated that the mechanism by which Rep represses
PPP1R12C transcription from the bidirectional promoter was
similar to what we observed with the PPP1R12Cp-mCherry re-
porter construct, we next investigated the effects of Rep on the
antisense promoter activity. Rep78 and Rep68 inhibit the anti-
sense transcriptional activity by 5- and 7-fold, respectively, while
Rep52 and Rep40 repress the antisense promoter by 2- and 3-fold,
respectively (Fig. 7B and C, EGFP). Western blot analysis showed
strong repression of the antisense promoter by all Rep proteins
(Fig. 7B and C, EGFP). In contrast to the wt Rep proteins, all Rep
NTP-binding mutants were unable to repress transcription from
the antisense promoter (Fig. 7B and C, EGFP). This observation
was also made for protein levels (Fig. 7B and C, EGFP).
Altogether, these results highlight the fact that, even though all
four Rep proteins inhibit transcription from both promoters,
there is a major difference in Rep78/Rep68-mediated transcrip-
tional repression of the sense and antisense promoters. While re-
pression of the PPP1R12C promoter requires the NTP-binding
motif in the central domain of the Rep proteins, as well as direct
interaction with the RBS, only the NTP-binding motif appears to
be required for Rep78/Rep68-mediated inhibition of the antisense
promoter. With regard to the small Rep proteins, our results sug-
gest that a similar mechanism is involved in Rep52/Rep40-medi-
ated repression of both PPP1R12C and antisense promoter activ-
ities and that this repression is dependent on the presence of a
functional NTP-binding motif.
DISCUSSION
The AAV Rep proteins are multifunctional proteins with the abil-
ity to regulate expression from cellular and viral promoters, in-
cluding the three AAV promoters p5, p19, and p40 (7). The rep-
lication phase of the AAV life cycle is strongly dependent on
controlled expression of AAV, as well as helper virus proteins, and
Rep’s role in this regulation has been well characterized (40).
However, much less is known about a potential role for Rep in the
regulation of cellular proteins that are involved in the different
aspects of the AAV life cycle. In particular, it is not known if Rep
has the ability to control the expression of the gene in which it
integrates to establish latency. In order to gain insight into a po-
tential additional regulatory role for Rep, we investigated if AAV2
infection and Rep expression influence the PPP1R12C promoter
activity and compared the effect to Rep-mediated repression of
the p5 promoter.
We have shown that AAV2 and adenovirus coinfection and the
associated increase in Rep expression lead to a decrease in
of each domain are shown above. The black bar shows the position of the NLS. Below are shown schematic representations of the various large Rep proteins
coexpressed with the PPP1R12Cp and p5 mCherry reporter plasmids. All Rep proteins lack endonuclease activity and contain mutations that avoid expression
of the small Rep proteins (M225G). The NTP-binding mutants harbor a mutation at amino acid position 340 (K340H). (B) Northern blot analysis shows
PPP1R12C (left) and p5 (right) transcription levels in 293T cells cotransfected with an mCherry reporter plasmid and various Rep-expressing plasmids.
Rep-mediated repressionwas analyzed on PPP1R12Cp and p5 reporter plasmids with unaltered, as well asmutated, RBS sequences that abolish Rep binding. The
blots were stripped and hybridized with a -actin cDNA probe (lower blots). Relative fold repression of mCherry expression is indicated at the bottom of the
blots. Western blot analysis shows the corresponding mCherry protein levels resulting from PPP1R12C (left) and p5 (right) promoter activity (top). Expression
of the large Rep proteins and correspondingNTP-bindingmutants was determined by hybridization with theN208 antibody. The blots were also incubated with
a -actin antibody, and relative fold repression was determined (indicated below the blots). Slot blot membranes hybridized to an mCherry probe show similar
plasmid uptake for all experimental conditions. (C) Determination of average mCherry expression levels from the PPP1R12C (left) and p5 (right) promoters
from3 independent experiments byNorthern andWestern blot analyses. Average fold repression ofmCherry expression is indicated at the bottomof each graph.
The error bars indicate SEM.
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PPP1R12C expression levels. The observed infection-induced
PPP1R12C repression appears to be different in 293T and HeLa
cells in that the observed repression can be seen in 293T cells
infected with AAV2 at high MOIs, a condition under which Rep
transcripts cannot be detected byNorthern blotting.However, the
presence of E1A and E1B in 293T cells leads to Rep levels that are
sufficient to support limited replication in the absence of helper
virus (17, 41) and is thus expected to also have an effect on
PPP1R12C transcription. An additional observation we made in
293T cells is that the level of repression in the presence of adeno-
virus appears to go upwith increasingMOIs despite declining Rep
transcripts. This decrease in Rep expression was not observed in
HeLa cells and could be due to differences in AAV replication
levels and autoregulatory feedback loops (41). The presence of
Rep transcripts in the absence of adenovirus infection and down-
regulation of Rep expression over timewere confirmed in the time
FIG 7 Analysis of the effects of the four Rep proteins and corresponding NTP-binding mutants on gene expression from the PPP1R12C sense and antisense
promoters. (A) Schematic representation of the PPP1R12Cp mCherry-GFP reporter plasmid. The Rep proteins that are coexpressed with the reporter plasmid
are depicted in Fig. 5 and 6. (B) Northern blot analysis shows mCherry (top) and GFP (bottom) transcripts driven by the sense and antisense promoters,
respectively. The blots were stripped and hybridized with a -actin cDNA probe, and the relative fold repression was calculated (indicated at the bottoms of the
mCherry and GFP blots). Western blot analysis shows the corresponding mCherry and GFP protein levels resulting from PPP1R12C (top) and antisense
promoter activity (second panel from top). Expression of the Rep proteins and corresponding NTP-binding mutants was determined by hybridization with the
226-7 antibody. The blots were also incubatedwith a-actin antibody, and the relative fold repressionwas determined (indicated below the blots). Slot blots were
hybridized to an mCherry and a GFP probe to determine cellular uptake of plasmid DNA. ND, not detected. (C) Determination of average EGFP and mCherry
expression levels from the PPP1R12C promoter from 3 independent experiments by Northern and Western blot analyses. Average fold repression of mCherry
and EGFP expression is indicated at the bottom of each graph. The error bars indicate SEM.
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course infection experiments in 293T cells. In summary, we ob-
served that under permissive conditions AAV2 infection causes
downregulation of PPP1R12C expression, which is potentially
mediated by Rep but not necessarily dependent on high levels of
Rep transcription.
Transfection-based experiments directly showed that the ob-
served effect is indeed mediated by Rep. In fact, we could show
that all four Rep proteins mediate repression of the endogenous
gene, as well as the PPP1R12C reporter construct, and that this
activity is directed by mechanisms similar to those employed by
the Rep proteins for the downregulation of the p5 promoter. As
was seen for repression of p5 transcription (19, 21), the large Rep
proteins display a stronger repressive effect on the PPP1R12C pro-
moter reporter constructs than the small Rep proteins (19, 21).
This difference could be attributed to the N-terminal DNA bind-
ing domain present in Rep78 and Rep68; however, this domain by
itself showed a decreased ability to suppress the PPP1R12C pro-
moter compared to the full-length large Rep proteins. It is likely
that the Rep78/Rep68-induced repression is dependent on the
final Rep78/Rep68 oligomeric complex that assembles on the p5
and PPP1R12C promoter sites. This event is mediated through
specific DNA binding dependent on the presence of the origin
binding domain (OBD), interdomain linker, and helicase domain
(42). Evidence from structural and biochemical experiments sug-
gests that the assembly of Rep78/Rep68 complexes on RBS-con-
taining DNA sites is both directional and highly cooperative (un-
published data). The X-ray structure of the OBD-RBS complex
shows that the Rep molecules bind to the RBS positions in such a
way that the C-terminal helicase domain is oriented upstream of
the 5=-GCTC-3= repeats, where it interacts with DNA nonspecifi-
cally (43). This model is supported by biochemical data showing
that the affinity of Rep68 for DNAwith only the minimal RBS site
is significantly lower than for sites that also include upstream se-
quences (32). In addition, footprinting experiments have shown
that Rep68 protects regions upstream of the RBS sequence (32).
Taken together, it appears that binding of Rep78/Rep68 to RBS
DNA sites is a highly cooperative event that requires the partici-
pation of all structural domains. Our model proposes that the
repression mechanism is a direct effect of Rep78/Rep68 either
blocking the start of transcription and/or binding of transcrip-
tional activators in both the p5 and thePPP1R12C promoters (Fig.
8). The different directionality of the 5=-GCTC-3= repeats in the
RBS of the p5 versus PPP1R12C promoter allows physical inter-
ference with the initiation of transcription despite their different
positions with respect to the transcriptional start site (Fig. 8). We
hypothesize that the K340Hmutationmay have an effect on DNA
affinity or complex formation, explaining the observed lower level
of repression in the context of the large Rep proteins and the p5
and sense PPP1R12C promoter. However, we cannot exclude the
possibility that an additional mechanism that is independent of
binding to the RBS but requires interactions with the NTPase
domain and cellular proteins also plays a role in Rep78/Rep68-
mediated repression.
Our data suggest that this mechanism is likely also responsible
for Rep78/Rep68-mediated repression of the antisense promoter,
which lacks the RBS and, similar to what was observed for other
heterologous promoters (21), requires only an intact NTP-bind-
ing motif. The small Rep proteins, which lack the OBD, might
exploit the aforementioned interactions with host cell proteins in
order to mediate repression of the p5 and PPP1R12C sense and
antisense promoters (Fig. 5 and 7). In addition, nonspecific DNA
binding activities of these proteins may also interfere with the
binding activities of proteins from the transcriptionmachinery by
masking binding sites; however, further studies need to be per-
formed to answer this question.
In summary, in addition to direct interactions with the pro-
moter site, transcriptional repression of both viral p5 and cellular
target site promoters may rely on interactions of Rep with factors
of the transcriptionmachinery. In fact, DNA-protein interactions,
as well as protein-protein interactions, have also been described
for Rep-mediated repression of the AdMLP (22). The close prox-
imity of the Rep binding site to the TATA element in AdMLP and
the observed interactions of Rep with TATA-binding protein
(TBP) have provoked the hypothesis that Rep could repress gene
expression by interferingwith the formation of the RNApolymer-
ase II preinitiation complex (22).
It could be hypothesized that Rep recruits factors that directly
act on RNA polymerase II or exert their function bymanipulating
the chromatin environment (44). Indeed, several Rep-interacting
partners have been identified, among which several proteins are
involved in transcriptional regulation: Sp1 (45, 46), high-mobility
group 1 (HMG1) nonhistone proteins (47), putative protein ki-
nase PKX and protein kinase A (48, 49), and transcriptional co-
activator PC4 (50, 51). The last is an ideal candidate, as Rep-PC4
interactions have been shown to be dependent on Rep’s NTPase
domain; however, preliminary knockdown experiments in our
FIG 8 Model of Rep-mediated repression of p5 and integration target site
promoters as mediated through OBD-RBS interactions. (Top) Rep78-Rep68-
mediated transcriptional repression of the p5 promoter. (Bottom) Rep78-
Rep68-mediated transcriptional repression of the PPP1R12C sense promoter.
The light-blue arrowheads depict transcription factor binding. The red arrows
indicate the positions of the transcriptional start sites. The black arrows indi-
cate the directions of the 5=-GCTC-3= repeats in the RBS. Ribbon representa-
tions of the Rep68 OBD (green), interdomain linkers (black), and NTPase
domains (blue) depict RBS binding and upstream positioning of the C-termi-
nal SF3 helicase domain, which interferes with the start of transcription and/or
binding of transcriptional activators to the promoter.
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laboratory did not affect Rep-mediated repression of the
PPP1R12C promoter (data not shown).
It is interesting to speculate that AAV2 has adapted to integrate
into a chromosomal site, which appears to be regulated by protein
complexes that also direct viral gene expression. In fact, once in-
tegrated, the virus may exploit these regulatory mechanisms in
order to silence the integration site and associated provirus to
maintain latency. Furthermore, the observation that the 5= end of
the provirus, containing the promoter region of recombinant or
wt AAV2, is usually found in the 5=-3= transcriptional direction of
the PPP1R12C gene (52) indicates that these transcriptional pro-
tein complexes may also be involved in the formation and posi-
tioning of the preintegration complex. Future work directed at
identifying Rep’s binding partners involved in transcriptional reg-
ulation might therefore also shed light on the intricacies of a
unique viral integration mechanism.
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